127 related articles for article (PubMed ID: 6981833)
21. Ten year follow-up in a case of T-cell chronic lymphocytic leukaemia. A morphological and cytochemical study in light-microscopy and in transmission electron microscopy.
Efrati P; Berrebi A; Nir E
Haematologica; 1983; 68(6):750-8. PubMed ID: 6421669
[No Abstract] [Full Text] [Related]
22. Costimulatory molecule CD154 in systemic lupus erythematosus and rheumatoid arthritis. Therapeutic perspectives.
Dejica DI; Manea EM
Roum Arch Microbiol Immunol; 2006; 65(1-2):66-74. PubMed ID: 17877113
[TBL] [Abstract][Full Text] [Related]
23. [Prevalence of extrahepatic illnesses in patients with chronic hepatitis b and hepatitis c: retrospective study of 435 patients].
Cesur S; Akin K; Albayrak F; Birengel S; Kurt H; Balik I
Mikrobiyol Bul; 2003; 37(2-3):187-93. PubMed ID: 14593902
[TBL] [Abstract][Full Text] [Related]
24. B-cell targeted therapies in rheumatoid arthritis and systemic lupus erythematosus.
Eisenberg R; Albert D
Nat Clin Pract Rheumatol; 2006 Jan; 2(1):20-7. PubMed ID: 16932648
[TBL] [Abstract][Full Text] [Related]
25. Prolymphocytic leukaemia: an ultrastructural study of 22 cases.
Costello C; Catovsky D; O'Brien M; Galton DA
Br J Haematol; 1980 Mar; 44(3):389-94. PubMed ID: 6966505
[TBL] [Abstract][Full Text] [Related]
26. [Activity of lysosomal hydrolase and acid phosphatase in T- and B-lymphocytes of healthy people and patients with chronic lymphatic leukemia (CLL)].
Meusers PJ; König E; Brittinger G; Fink U
Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1609-12. PubMed ID: 1088529
[No Abstract] [Full Text] [Related]
27. Defective major histocompatibility complex class I expression on lymphoid cells in autoimmunity.
Fu Y; Nathan DM; Li F; Li X; Faustman DL
J Clin Invest; 1993 May; 91(5):2301-7. PubMed ID: 8486790
[TBL] [Abstract][Full Text] [Related]
28. [Surface nature of B and T cell in chronic lymphocytic leukemia (author's transl)].
Kamihira S; Kinosita K; Nagiri A; Nonaka M
Rinsho Ketsueki; 1974 Nov; 15(11):1203-11. PubMed ID: 4549515
[No Abstract] [Full Text] [Related]
29. The quantitative analysis of peripheral blood FOXP3-expressing T cells in systemic lupus erythematosus and rheumatoid arthritis patients.
Lin SC; Chen KH; Lin CH; Kuo CC; Ling QD; Chan CH
Eur J Clin Invest; 2007 Dec; 37(12):987-96. PubMed ID: 18036033
[TBL] [Abstract][Full Text] [Related]
30. Increased Fas and Bcl-2 expression on peripheral blood T and B lymphocytes from juvenile-onset systemic lupus erythematosus, but not from juvenile rheumatoid arthritis and juvenile dermatomyositis.
Liphaus BL; Kiss MH; Carrasco S; Goldenstein-Schainberg C
Clin Dev Immunol; 2006; 13(2-4):283-7. PubMed ID: 17162369
[TBL] [Abstract][Full Text] [Related]
31. [Peripheral blood, thymus and PHA-transforming lymphocytes were studied by scanning electron microscopy (author's transl)].
Piqueras JR; Ramon AM; Bover GF
Sangre (Barc); 1975; 20(2):134-49. PubMed ID: 1079971
[No Abstract] [Full Text] [Related]
32. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
[TBL] [Abstract][Full Text] [Related]
33. Do elevated levels of serum-soluble fas contribute to the persistence of activated lymphocytes in systemic lupus erythematosus?
Bijl M; van Lopik T; Limburg PC; Spronk PE; Jaegers SM; Aarden LA; Smeenk RJ; Kallenberg GG
J Autoimmun; 1998 Oct; 11(5):457-63. PubMed ID: 9802929
[TBL] [Abstract][Full Text] [Related]
34. Value of the lymphocyte nucleolar parameters for the estimation of therapy effectiveness in chronic diseases with immune lymphocyte involvement.
Micu D; Mihăilescu E; Sighetea E; Olinescu V; Constantineanu I
Med Interne; 1979; 17(3):285-91. PubMed ID: 583079
[No Abstract] [Full Text] [Related]
35. [Studies on leukemic cells in chronic lymphatic leukemia. Especially on the scanning electron microscopic observation (author's transl)].
Nakajima H; Uchiyama M; Kameda Y; Ikezawa Z; Nagai R
Nihon Hifuka Gakkai Zasshi; 1974 Oct; 84(10):481-4. PubMed ID: 4548452
[No Abstract] [Full Text] [Related]
36. Association study between B- and T-lymphocyte attenuator gene and type 1 diabetes mellitus or systemic lupus erythematosus in the Japanese population.
Inuo M; Ihara K; Matsuo T; Kohno H; Hara T
Int J Immunogenet; 2009 Feb; 36(1):65-8. PubMed ID: 19207938
[TBL] [Abstract][Full Text] [Related]
37. [Relative polyribosome content in peripheral blood lymphocytes and lymphoid organs in the human].
Morozova EO; Blinov MN
Tsitologiia; 1982 Jul; 24(7):764-9. PubMed ID: 6982547
[TBL] [Abstract][Full Text] [Related]
38. CD4(+)CD25 (+) regulatory T cells in human lupus erythematosus.
Kuhn A; Beissert S; Krammer PH
Arch Dermatol Res; 2009 Jan; 301(1):71-81. PubMed ID: 18985367
[TBL] [Abstract][Full Text] [Related]
39. [Systemic lupus erythematosus and antiphospholipid syndrome].
Gröne HJ
Verh Dtsch Ges Pathol; 1996; 80():21-37. PubMed ID: 9065004
[TBL] [Abstract][Full Text] [Related]
40. Differential control of CD22 ligand expression on B and T lymphocytes, and enhanced expression in murine systemic lupus.
Lajaunias F; Ida A; Kikuchi S; Fossati-Jimack L; Martinez-Soria E; Moll T; Law CL; Izui S
Arthritis Rheum; 2003 Jun; 48(6):1612-21. PubMed ID: 12794829
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
